Navigation Links
Elsevier introduces innovative new pharmacology text
Date:12/7/2009

Philadelphia, PA, 7 December 2009 Elsevier, the world-leading publisher of scientific, technical and medical information products and services, proudly announces the early success and rapid acceptance of its recently released Pharmacology and Therapeutics: Principles to Practice (http://www.us.elsevierhealth.com/isbn/9781416032915/Pharmacology-and-Therapeutics), an innovative new pharmacology textbook designed to better meet the needs of today's residents and practitioners. In just a few short months since its introduction, the book has garnered critical acclaim and has earned its place among other more established pharmacology reference books (http://www.us.elsevierhealth.com/medicine/pharmacology).

Up until now, pharmacology references have focused on either the basic or clinical aspects of the field. By contrast, Pharmacology and Therapeutics encompasses the entire continuum from underlying science through innovation, translation, regulation, and clinical implementation, providing the integrated perspectives that are needed to fully master human therapeutics today.

Edited by Drs. Scott Waldman and Andre Terzic both past presidents of the American Society for Clinical Pharmacology and Therapeutics the book features contributions from many of the most respected names in pharmacology. These authors, all leaders in their respective disciplines, establish the standards for translating fundamental observations in the laboratory into novel therapeutic approaches for managing patients including rapidly growing areas such as pharmacogenetics and pharmacogenomics, regenerative pharmacology, stem cell therapies, and the emerging field of individualized medicine. Evidence-based therapeutic guidelines are included throughout, where available, as are appropriate discussions of nutrition, complementary and alternative medicines, nutraceuticals, and dietary supplements.

"I applaud the Editors for bringing together, between the covers of this first edition, a superb textbook bridging basic and clinical pharmacology, from classic principles to future concepts," writes Nobel Laureate Ferid Murad, MD, PhD in the book's Foreword. "This exciting textbook will be invaluable to students, scholars, and professionals across the practice in human therapeutics."

"This is an outstanding textbook that connects the recent advances in basic principles with the practice of medicine," added Thomas L. Pazdernik, PhD, University of Kansas Medical Center. "It is a must-have book for those involved in drug discovery, translational research, and the teaching of evidence-based medicine."

In its June 2009 issue, the British Journal of Hospital Medicine cites the narrative as " so easy to read that it makes extracting the information from the pages almost effortless. Every chapter is supported by a good selection of references to original research and review articles, both old and new, and the whole text is available online allowing it to be accessed wherever there is internet connection."


'/>"/>

Contact: Tom Reller
t.reller@elsevier.com
212-462-1912
Elsevier
Source:Eurekalert

Related medicine news :

1. Elsevier launches new journal: Stem Cell Research
2. Elsevier announces new journal on inflammatory bowel diseases
3. Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
4. Excerpta Medica and Elsevier Interactive Solutions merge into 1 integrated provider
5. Elsevier journals participate widely in global theme issue on poverty and human development
6. ScienceDirect to host French-language journals from Elsevier Masson
7. Elseviers "WiserWiki" Allows Physicians to Update Evidence-Based Medical Information With Experience-Based Practice Insights
8. Elseviers WiserWiki allows physicians to update evidence-based medical information
9. Elsevier Foundation Announces Grants for Innovative Libraries and New Scholars
10. Elsevier Foundation announces grants for innovative libraries and new scholars
11. Elsevier enhances clinical decision making with suite of Clinical Decision Support solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... 06, 2016 , ... GrekTek LLC, ( http://www.grektek.com ) an ... http://kck.st/2g3a1so ) for the HealthyWatch, a new device to help patients manage their ... watch while sharing these events with caregivers in real time. , ...
(Date:12/6/2016)... ... December 06, 2016 , ... Keeping Gift Season Safe, In a season stacked ... and age-appropriate for their recipients. This is the idea behind Safe Toys and Gifts ... items that would make good gifts for children. For companies that produce goods that ...
(Date:12/6/2016)... Overland Park, KS (PRWEB) , ... December 06, 2016 , ... ... online retailers of Mobility Scooters . , Mobility Scooters give freedom to people ... and balance problems. Still others may be facing a long period of rehabilitation after ...
(Date:12/6/2016)... ... December 06, 2016 , ... U.S. Security Associates (USA) was ... for their industry leading training methods that engage their associates and link their ... global elite in employer-sponsored training and development programs. , “The 2017 Training Top ...
(Date:12/5/2016)... ... December 05, 2016 , ... Edward ... to announce the arrival of the newest Sciton laser in January 2017. The ... use tunable non-ablative and ablative wavelengths for exceptional results. Outperforming more traditional lasers, ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... YORK , Dec. 5, 2016  Balloon catheter ... catheter, which is inserted into the femoral artery in ... the arm to treat constricted blood vessels. These products ... due to atherosclerosis – deposition of lipid substances in ... balloon catheter market is projected to expand at a ...
(Date:12/5/2016)... Spain Glaucoma Surgery Devices Market Outlook to ... Surgery Devices Market Outlook to 2022", provides key market ... report provides value, in millions of US dollars, volume ... - Canaloplasty Micro Catheters and Glaucoma Drainage Devices. ... data for each of these market segements, and global ...
(Date:12/5/2016)... Dec. 5, 2016  Cornerstone Pharmaceuticals, Inc., a ... data from two Phase I trials evaluating its ... 58th annual meeting of the American Society of ... . The two datasets show encouraging efficacy ... leukemia (AML) and T-cell non-Hodgkin,s lymphoma (T-cell NHL), ...
Breaking Medicine Technology: